NCT04043897View on ClinicalTrials.gov

Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis

PHASE2RecruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

June 29, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Microscopic Colitis

Interventions

DRUG

Rifaximin 550mg

Rifaximin 550mg

Trial Locations (1)

60201

RECRUITING

NorthShore University HealthSystem, Evanston

All Listed Sponsors

lead

Eugene F Yen, MD

OTHER